Orasis Pharmaceuticals Is An Ophthalmic Pharmaceutical Company Focused On Developing Innovative Solutions For Vision Correctionthe Company Is Led By A Team Of Experienced Industry Executives And Eye Care Professionals Dedicated To Improving Patient Outcomes Their Primary Product Is Qlosia Cpilocarpine Hcl An Fda Approved Prescription Eye Drop Designed To Treat Presbyopiaa Condition That Affects Near Visionorasis Pharmaceuticals Aims To Provide Alternatives To Traditional Vision Correction Methodsenhancing Convenience For Patients The Company Has Established Strategic Partnershipsincluding A Licensing Agreement With Optus Pharmaceuticals For The Korean Marketorasis Has Also Secured Significant Fundingcompleting A $78 Million Financing Round In October 2024 To Support The Commercial Launch Of Its Productstheir Mission Is To Empower Patients By Improving Their Quality Of Life Through Innovative Ophthalmic Solutions
No conferences found for this company.
| Company Name | Orasis Pharmaceuticals Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
